LL-37 Research
Mahlapuu 2021 - HEAL LL-37 Phase IIb Trial in Venous Leg Ulcers
Wound Repair and Regeneration·October 1, 2021
M. Mahlapuu
Summary
HEAL LL-37 evaluated efficacy and safety of LL-37 in hard-to-heal venous leg ulcers, adding later-stage clinical evidence to the LL-37 wound-healing literature.
Study Details
Study Design
Phase IIb double-blind randomized placebo-controlled trial
Indication
Hard-to-heal venous leg ulcers
Intervention
Topical LL-37 cream vs placebo
Species
Human
Risk of Bias Assessment
Phase IIb wound trial
Tags
SourceRCTPhase2bLl 37Venous Leg UlcerWound Healing
External Links
Metrics
Citations
48Evidence QualityN/A
Last VerifiedMay 9, 2026
Related PeptideLL-374 papers